JP Morgan Put 195 BIIB 17.01.2025/ DE000JT769P7 /
| 9/2/2024 11:59:53 AM | Chg.- | Bid11:11:10 AM | Ask11:11:10 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.04EUR | - | 1.05 Bid Size: 2,000 |
1.20 Ask Size: 2,000 |
Biogen Inc | 195.00 USD | 1/17/2025 | Put |
GlobeNewswire
9/1
SAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Invest...
GlobeNewswire
8/29
SAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investo...
GlobeNewswire
8/19
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire
8/15
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire
8/1
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
8/1
Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
7/31
Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
GlobeNewswire
7/30
New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecane...
GlobeNewswire
7/30
Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...
GlobeNewswire
7/30
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Path...
GlobeNewswire
7/26
CVS Health Corporation Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law...
GlobeNewswire
7/26
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
GlobeNewswire
7/26
BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Long-Term Stockh...
GlobeNewswire
7/22
Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Fir...
GlobeNewswire
7/22
DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire
7/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire
7/20
BIIB DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Biogen Inc. (BIIB) Se...
GlobeNewswire
7/19
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors wit...
GlobeNewswire
7/18
DEADLINE ALERT for CMBM, BIIB, DRCT, FSLY: Law Offices of Howard G. Smith Reminds Investors of Class...
